Barclays Capital (BCS) Analysts Begin Coverage on Cemex SAB de CV (CX)
Wednesday, June 29, 2021 1:00 PM

Related Stories

Equities research analysts at Barclays Capital (NYSE: BCS) initiated coverage on shares of Cemex SAB de CV (NYSE: CX) in a research note to investors on Wednesday. The analysts set an "equal weight" rating and a $9.00 price target on the stock.

Separately, analysts at Zacks Investment Research upgraded shares of Cemex SAB de CV from an "underperform" rating to a "neutral" rating in a research note to investors on Tuesday, May 17th.

Shares of Cemex SAB de CV traded up 3.74% during mid-day trading on Thursday, hitting $8.59. Cemex SAB de CV has a 52 week low of $7.46 and a 52 week high of $11.47. The stock's 50-day moving average is $8.12 and its 200-day moving average is $9.09. The company has a market cap of $8.938 billion.

CEMEX, S.A.B. de C.V. (CEMEX) is a global cement manufacturer with operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East and Asia. The Company is a holding company engaged through the operating subsidiaries in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates and clinker. As of December 31, 2009, the Company’s cement production facilities were located in Mexico, the United States, Spain, the United Kingdom, Germany, Poland, Croatia, Latvia, Colombia, Costa Rica, the Dominican Republic, Panama, Nicaragua, Puerto Rico, Egypt, the Philippines and Thailand.

Stay on top of analysts' coverage with American Banking & Market News' daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day.Click here to register.